title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma | DelveInsight",20231122T220100,https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-b-cell-lymphomas-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-mantle-cell-lymphoma-marginal-zone-lymphoma-waldenstrom-macroglobulinemia-and-burkitt-lymphoma--301995626.html,DSKYF,0.013173,Neutral,-0.019011
Esperion  ( ESPR )  Settles Milestone Dispute With Daiichi Sankyo,20240104T160800,https://www.zacks.com/stock/news/2205756/esperion-espr-settles-milestone-dispute-with-daiichi-sankyo,DSKYF,0.060388,Neutral,0.088
Colorectal Cancer Treatment Drug Market to Show Immense Growth During the Study Period  ( 2019-2032 )  | DelveInsight,20231121T220100,https://www.prnewswire.com/news-releases/colorectal-cancer-treatment-drug-market-to-show-immense-growth-during-the-study-period-20192032--delveinsight-301994315.html,DSKYF,0.046184,Neutral,-0.012968
"Small-Cell Lung Cancer Market to Accelerate Substantially During the Study Period  ( 2019-2032 ) , Assesses DelveInsight | Leading Companies - Amgen, Novartis, AbbVie, BMS, Clovis Oncology, Cardiff Oncology, Roche, Daiichi Sankyo",20231004T210100,https://www.prnewswire.com/news-releases/small-cell-lung-cancer-market-to-accelerate-substantially-during-the-study-period-20192032-assesses-delveinsight--leading-companies----amgen-novartis-abbvie-bms-clovis-oncology-cardiff-oncology-roche-daiichi-sankyo-301946615.html,DSKYF,0.065268,Neutral,-0.0392
"Neuropathy Pain Treatment Market size to grow by USD 5.84 billion from 2023 to 2028, North America accounts for 33 ... - PR Newswire",20231214T221500,https://www.prnewswire.com/news-releases/neuropathy-pain-treatment-market-size-to-grow-by-usd-5-84-billion-from-2023-to-2028--north-america-accounts-for-33-of-market-growth--technavio-302015282.html,DSKYF,0.078099,Neutral,0.0
"Breast Cancer Monoclonal Antibodies Market to grow by USD 15 billion from 2022 to 2027, North America to account ... - PR Newswire",20230918T091500,https://www.prnewswire.com/news-releases/breast-cancer-monoclonal-antibodies-market-to-grow-by-usd-15-billion-from-2022-to-2027-north-america-to-account-for-42-of-market-growth---technavio-301929309.html,DSKYF,0.043108,Neutral,0.0
Antibody-drug Conjugates Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain,20230626T210100,https://www.prnewswire.com/news-releases/antibody-drug-conjugates-clinical-trial-pipeline-experiences-momentum-delveinsight-estimates-a-diverse-pipeline-comprising-180-companies-working-in-the-domain-301862784.html,DSKYF,0.041791,Neutral,0.034859
Gilead Sciences  ( GILD )  Q4 2022 Earnings Call Transcript,20230203T020023,https://www.fool.com/earnings/call-transcripts/2023/02/02/gilead-sciences-gild-q4-2022-earnings-call-transcr/,DSKYF,0.004354,Neutral,0.072867
"With 14.1% CAGR, Monoclonal Antibody Therapy Market Size Worth USD 451.89 Billion by 2028",20230130T105418,https://www.benzinga.com/pressreleases/23/01/g30618366/with-14-1-cagr-monoclonal-antibody-therapy-market-size-worth-usd-451-89-billion-by-2028,DSKYF,0.035983,Somewhat-Bearish,-0.268668
Why MacroGenics Stock Sank Today,20220912T231457,https://www.fool.com/investing/2022/09/12/why-macrogenetics-stock-sank-today/,DSKYF,0.254307,Neutral,0.090638
Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Summit Therapeutics  ( NASDAQ:SMMT ) ,20240909T100836,https://www.benzinga.com/news/24/09/40768801/why-summit-therapeutics-shares-are-trading-higher-by-around-18-here-are-20-stocks-moving-premarket,DSKYF,0.063594,Somewhat-Bearish,-0.203312
"Nasdaq Down Over 100 Points; Sidus Space Shares Spike Higher - Esperion Therapeutics  ( NASDAQ:ESPR ) , Nemaura Medical  ( NASDAQ:NMRD ) ",20240103T192005,https://www.benzinga.com/news/earnings/24/01/36476440/nasdaq-down-over-100-points-sidus-space-shares-spike-higher,DSKYF,0.074001,Neutral,0.081648
"Crude Oil Gains Over 3%; US Manufacturing Activity Contracts For 14th Consecutive Month - Esperion Therapeutics  ( NASDAQ:ESPR ) , Nemaura Medical  ( NASDAQ:NMRD ) ",20240103T170106,https://www.benzinga.com/news/earnings/24/01/36473906/crude-oil-gains-over-3-us-manufacturing-activity-contracts-for-14th-consecutive-month,DSKYF,0.074692,Neutral,0.081713
AstraZeneca's  ( AZN )  sBLA for Enhertu Gets FDA's Priority Tag,20240130T124400,https://www.zacks.com/stock/news/2217677/astrazenecas-azn-sbla-for-enhertu-gets-fdas-priority-tag,DSKYF,0.053992,Neutral,-0.074092
"Triple-Negative Breast Cancer Market to Accelerate Substantially During the Forecast Period  ( 2023-2032 ) , Examines DelveInsight | Key Companies to Watch - Roche, AbbVie, AstraZeneca, BeiGene, GlaxoSmithKline, Genentech, Eli Lilly, Novartis",20230906T210100,https://www.prnewswire.com/news-releases/triple-negative-breast-cancer-market-to-accelerate-substantially-during-the-forecast-period-20232032-examines-delveinsight--key-companies-to-watch---roche-abbvie-astrazeneca-beigene-glaxosmithkline-genentech-eli-lilly--301918858.html,DSKYF,0.022494,Neutral,0.023078
Rigel Reports Second Quarter 2022 Financial Results and Provides Business Update,20220802T200200,https://www.prnewswire.com/news-releases/rigel-reports-second-quarter-2022-financial-results-and-provides-business-update-301598393.html,DSKYF,0.011117,Neutral,-0.044414
Rigel Reports First Quarter 2022 Financial Results and Provides Business Update,20220503T200100,https://www.prnewswire.com/news-releases/rigel-reports-first-quarter-2022-financial-results-and-provides-business-update-301538880.html,DSKYF,0.012421,Neutral,0.001782
"Acute Lymphocytic Leukemia Market to Accelerate Substantially by 2032, Assesses DelveInsight | Key Companies in the Market - Beam, Pfizer, Genentech, AbbVie, Fate, Roche, Ascentage, Janssen, Jazz, ADC, Kymera, Syndax, ImmunoGen",20230913T210100,https://www.prnewswire.com/news-releases/acute-lymphocytic-leukemia-market-to-accelerate-substantially-by-2032-assesses-delveinsight--key-companies-in-the-market---beam-pfizer-genentech-abbvie-fate-roche-ascentage-janssen-jazz-adc-kymera-syndax-immunogen-301925772.html,DSKYF,0.021897,Neutral,0.0
Seagen Inc.  ( SGEN )  Q3 2022 Earnings Call Transcript,20221028T063039,https://www.fool.com/earnings/call-transcripts/2022/10/28/seagen-inc-sgen-q3-2022-earnings-call-transcript/,DSKYF,0.005164,Neutral,0.037301
Molecular Glues Clinical Trial Pipeline Appears Robust With 10+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight,20240711T213100,https://www.prnewswire.com/news-releases/molecular-glues-clinical-trial-pipeline-appears-robust-with-10-key-pharma-companies-actively-working-in-the-therapeutics-segment--delveinsight-302194515.html,DSKYF,0.049784,Neutral,-0.052735
"RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships",20240610T123000,https://www.globenewswire.com/news-release/2024/06/10/2895991/0/en/RenovoRx-Appoints-Ryan-Witt-as-Senior-Vice-President-Head-of-Corporate-Strategy-and-Partnerships.html,DSKYF,0.025985,Neutral,0.100794
"RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships - Immix Biopharma  ( NASDAQ:IMMX ) , RenovoRx  ( NASDAQ:RNXT ) ",20240610T123000,https://www.benzinga.com/pressreleases/24/06/g39249080/renovorx-appoints-ryan-witt-as-senior-vice-president-head-of-corporate-strategy-and-partnerships,DSKYF,0.025139,Neutral,0.100354
